Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-064252
Filing Date
2022-05-24
Accepted
2022-05-24 16:18:20
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2216688-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2216688-5_4seq1.xml 4 4001
  Complete submission text file 0001104659-22-064252.txt   5434
Mailing Address C/O SYNERGY PHARMACEUTICALS INC. 420 LEXINGTON AVE NEW YORK NY 10020
Business Address
Sender Gary (Reporting) CIK: 0001659085 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 22956893

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations